Table 2.

Comparison of early neurological deterioration between groups.

	Urokinase	Urokinase + tirofiban	OR (95%CI)	P
END1d (n/%)	4/57.14	4/40.00	0.500 (0.070–3.550)	0.637
END3d (n/%)	6/85.71	1/10.00	0.019 (0.001–0.357)	0.004
END5d (n/%)	6/85.71	2/20.00	0.042 (0.003–0.574)	0.013

OR: odds ratio; CI: confidence interval; END1d: early neurological deterioration on day 1; END3d: early neurological deterioration on day 3; END5d: early neurological deterioration on day 5. Qualitative data are expressed as rates and were compared using the chi-squared or Fisher’s exact test.